Safinamide
CAS 133865-89-1 4 FDA-DMF suppliersSmall Molecule
Overview
Safinamide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL396778).
API suppliers (1)
Suppliers of Safinamide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Merck KGaAGermany
Patent & exclusivity (US)
Per the FDA Orange Book (8 approved US products), the latest listed US patent on Safinamide expires 21 Mar 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
- Canonical SMILES
- C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F
- InChIKey
- NEMGRZFTLSKBAP-LBPRGKRZSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.